Esophageal cancer: emerging therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Esophageal cancer: emerging therapeutics

Published:2022-02-01 Issue:2 Volume:26 Page:107-117
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Rogers Jane E.¹,Sewastjanow-Silva Matheus²^ORCID,Waters Rebecca E.³,Ajani Jaffer A.²

Affiliation:

1. Pharmacy Clinical Programs U.T. M.D. Anderson Cancer Center, Houston, TX, USA

2. Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, TX, US

3. Department of Anatomical Pathology, U.T. M.D. Anderson Cancer Center, Houston, TX, US

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2036718

Reference76 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Network, N.C.C. Esophageal and esophagogastric junction cancers version 4.2021.

3. Esophageal Cancer: An Updated Review

4. The management of localized esophageal squamous cell carcinoma: Western approach

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copper complex@Paclitaxel: A new dual-functional fluorescent-responsive composite material and treatment on esophageal cancer cells;Inorganica Chimica Acta;2024-10

2. A causal association between esophageal cancer and the oral microbiome: a Mendelian randomization study based on an Asian population;Frontiers in Cellular and Infection Microbiology;2024-09-13

3. Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis;PeerJ;2024-09-11

4. Modulation of esophageal squamous cell carcinoma progression: the impact of CCR7 on JAK2/STAT3 signaling pathway;Discover Oncology;2024-09-10

5. Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis;Asian Journal of Surgery;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3